Schedule 13G ownership disclosure
APTEVO THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 03835L504
Event date: 2025-09-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 299,944.00 · Class: 9.1%
- Point72 Capital Advisors, Inc.
Shares: 299,944.00 · Class: 9.1%
- Steven A. Cohen
Shares: 299,944.00 · Class: 9.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-004113
- Form type
- SCHEDULE 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Sep 17, 2025
- Reporting period
- Sep 16, 2025
- Description
- Schedule 13G beneficial ownership